Underwriting the cost of Carnitor injection to certain individuals under a "Reimbursement Guarantee" program initiated Dec. 1. Sigma Tau says the guarantee is designed to respond to "reimbursement problems," noting that some payers have "failed to understand the distinction between pharmaceutical grade levocarnitine and the 'health food' supplement L-carnitine." The initial program was designed to cover purchases of the drug before Jan. 15...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth